Search
Descriptor English: Chlorisondamine
Descriptor Spanish: Clorisondamina
Descriptor clorisondamina
Scope note: Antagonista nicotínico que se utiliza principalmente como bloqueante ganglionar en investigación animal. Se ha utilizado como agente antihipertensor pero ha sido suplantado por fármacos más específicos en la mayoría de sus aplicaciones clínicas.
Descriptor Portuguese: Clorisondamina
Descriptor French: Chlorisondamine
Entry term(s): Chlorure de chlorisondamine
Tree number(s): D02.092.877.883.222
D02.675.276.200
D03.633.100.513.249
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D002714
Scope note: A nicotinic antagonist used primarily as a ganglionic blocker in animal research. It has been used as an antihypertensive agent but has been supplanted by more specific drugs in most clinical applications.
Allowable Qualifiers: AA analogues et dérivés
AD administration et posologie
AE effets indésirables
AG agonistes
AI antagonistes et inhibiteurs
AN analyse
BL sang
CF liquide cérébrospinal
CH composition chimique
CL classification
CS synthèse chimique
EC économie
HI histoire
IM immunologie
IP isolement et purification
ME métabolisme
PD pharmacologie
PK pharmacocinétique
PO intoxication
RE effets des radiations
SD ressources et distribution
ST normes
TO toxicité
TU usage thérapeutique
UR urine
Pharm Action: Antihypertensive Agents
Ganglionic Blockers
Nicotinic Antagonists
Registry Number: JD3M24F66I
CAS Type 1 Name: 1H-Isoindolium, 4,5,6,7-tetrachloro-2,3-dihydro-2-methyl-2-(2-(trimethylammonio)ethyl)-, dichloride
DeCS ID: 2759
Unique ID: D002714
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 1966/01/01
Date of Entry: 1999/01/01
Revision Date: 2016/05/28
Chlorisondamine - Preferred
Concept UI M0004145
Preferred term Chlorisondamine
Chlorure de chlorisondamine - Narrower
Concept UI M0004146
Preferred term Chlorure de chlorisondamine



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey